Makerere University Research Repository >
College of Health Sciences >
School of Bio-Medical Sciences >
Research Articles (Bio-Medical) >
Please use this identifier to cite or link to this item:
|Title: ||Direct susceptibility testing for multi drug resistant tuberculosis: A meta-analysis|
|Authors: ||Bwanga, Freddie|
Joloba, Moses L.
|Issue Date: ||20-May-2009 |
|Publisher: ||BioMed Central|
|Citation: ||BMC Infectious Diseases 2009, 9:67|
|Abstract: ||Background: One of the challenges facing the tuberculosis (TB) control programmes in resourcelimited settings is lack of rapid techniques for detection of drug resistant TB, particularly multi drug resistant tuberculosis (MDR TB). Results obtained with the conventional indirect susceptibility testing methods come too late to influence a timely decision on patient management. More rapid tests directly applied on sputum samples are needed. This study compared the sensitivity, specificity and time to results of four direct drug susceptibility testing tests with the conventional indirect
testing for detection of resistance to rifampicin and isoniazid in M. tuberculosis. The four direct tests
included two in-house phenotypic assays – Nitrate Reductase Assay (NRA) and Microscopic Observation Drug Susceptibility (MODS), and two commercially available tests – Genotype® MTBDR and Genotype® MTBDRplus (Hain Life Sciences, Nehren, Germany).
Methods: A literature review and meta-analysis of study reports was performed. The Meta-Disc software was used to analyse the reports and tests for sensitivity, specificity, and area under the summary receiver operating characteristic (sROC) curves. Heterogeneity in accuracy estimates
was tested with the Spearman correlation coefficient and Chi-square.
Results: Eighteen direct DST reports were analysed: NRA – 4, MODS- 6, Genotype MTBDR® – 3 and Genotype® MTBDRplus – 5. The pooled sensitivity and specificity for detection of resistance to rifampicin were 99% and 100% with NRA, 96% and 96% with MODS, 99% and 98% with Genotype® MTBDR, and 99% and 99% with the new Genotype® MTBDRplus, respectively. For isoniazid it was 94% and 100% for NRA, 92% and 96% for MODS, 71% and 100% for Genotype® MTBDR, and 96% and 100% with the Genotype® MTBDRplus, respectively. The area under the summary receiver operating characteristic (sROC) curves was in ranges of 0.98 to 1.00 for all the four tests. Molecular tests were completed in 1 – 2 days and also the phenotypic assays were much more rapid than conventional testing.
Conclusion: Direct testing of rifampicin and isoniazid resistance in M. tuberculosis was found to be highly sensitive and specific, and allows prompt detection of MDR TB.|
|Description: ||This article is available from http://www.biomedcentral.com/1471-2334/9/67|
|Appears in Collections:||Research Articles (Bio-Medical)|
Files in This Item:
All items in DSpace are protected by copyright, with all rights reserved.